CEO Phillip Chan highlighted a 25% growth in Q4 product revenue, reaching $9.2 million, and $35.6 million in total product revenue for 2024, representing a 15% annual growth. He emphasized strong ...
In June 2022 ATR become the first to fly a commercial aircraft with 100% SAF in both engines and it is targeting 2025 for 100% SAF readiness. Credit: ATR ATR recently published a summary of its ...
There have been numerous unexpected changes recently to ATR’s environment—in geopolitics, competition and customer fleet policy. Meanwhile, some anticipated changes in foreign regulations and within ...
An update from Rakovina Therapeutics Inc ( (TSE:RKV)) is now available. At the 9th Annual DDR Inhibitors Summit, Rakovina reported strong industry validation for its brain-penetrant dual ATR/mTOR ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results